Don’t let the high cost of brand nifurtimox disrupt your Chagas disease treatment. We help eligible families access Lampit (nifurtimox tablets) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
The Lampit Patient Assistance Program helps eligible families access Lampit for pediatric Chagas disease at little or no cost when meeting income, insurance, and clinical criteria.
At AffordMyPrescriptions, our Patient Advocates handle the entire Lampit PAP enrollment for a flat $69.95 per month — so families never face a gap in Lampit therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Lampit enrollment — so families never face a gap in pediatric Chagas disease treatment.
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| ID/tropical medicine consult | varies | Specialist guidance |
| Walgreens | ~$780/course | Save substantially |
| CVS Pharmacy | ~$800/course | Save substantially |
| Walmart | ~$500/course | Save substantially |
| Specialty pharmacy | ~$400/course | Save substantially |
| Benznidazole (alt for Chagas) | ~$400/course | Alt first-line Chagas therapy |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Lampit — independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Lampit Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Benznidazole is also FDA-approved for pediatric Chagas — choice depends on tolerability, availability, and prescriber preference.
Complete a simple eligibility form so our team can determine if you may qualify for Lampit assistance.
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Once approved, your Lampit is delivered through the assistance program while we manage refills and annual renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Lampit:
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $400–$800/course even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Fixed $69.95/month — never changes regardless of retail price
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Lampit assistance.
Lampit (nifurtimox) is one of two FDA-approved therapies for Chagas disease. A nitrofuran antiprotozoal — it generates reactive oxygen species that kill T. cruzi parasites. Approved for pediatric use (birth to <18 years). Adult use in the US is typically off-label or via investigational protocols; benznidazole is the traditional first-line agent.
How It Works:
Chagas disease is caused by Trypanosoma cruzi — a protozoan parasite transmitted primarily via the triatomine (‘kissing bug’) vector in Latin America, but also congenitally, via blood transfusion, organ transplantation, and orally via contaminated food. Chronic infection can cause cardiomyopathy (Chagas heart disease — a major cause of heart failure in Latin America) and gastrointestinal disease (megaesophagus, megacolon) decades after initial infection. Nifurtimox is a nitrofuran reduced by parasite enzymes to reactive intermediates — generating reactive oxygen species and inhibiting parasite trypanothione reductase to kill T. cruzi. Effective in acute and early chronic Chagas; less effective in longstanding chronic infection where organ damage has occurred. Prompt treatment of acute or reactivation disease and pediatric chronic disease improves outcomes.
Form and Use:
Lampit 30 mg or 120 mg tablets. Weight-based dosing: 10–15 mg/kg/day divided in 3 doses (typically a 60-day course). Take with food to reduce GI side effects. Pediatric-approved (birth to <18 years). Adult use in the US is off-label. Complete the full 60-day course even if side effects occur. Discuss with a pediatric infectious disease or tropical medicine specialist.
Generic Availability:
No generic Lampit. Alternative Chagas therapy: benznidazole (Rochagan and other trade names; various generics globally — historically first-line adult and pediatric treatment; FDA-approved for pediatric use in the US since 2017). Both nifurtimox and benznidazole have significant side effect burden in adults but better pediatric tolerability. Neither is perfectly effective in chronic disease. The CDC provides Chagas diagnostic and treatment guidance. Infectious disease or tropical medicine consultation is recommended. Screening: serologic testing (two different tests recommended for confirmation). Congenital screening in babies born to seropositive mothers. Blood bank screening in the US. Chagas Foundation and other advocacy resources.
Warnings:
Central and peripheral neurotoxicity (peripheral neuropathy, seizures — monitor and hold for severe), embryo-fetal toxicity (contraindicated in pregnancy — animal teratogenicity), severe skin reactions (SJS/TEN — rare), porphyria (contraindicated), impaired mental health (depression, anxiety, psychosis — monitor). Other: nausea, vomiting, abdominal pain, anorexia, weight loss (very common — monitor and provide nutritional support), headache, insomnia, dizziness. Avoid alcohol during therapy (disulfiram-like reaction). Drug interactions with several classes.
$400–$800 for a full 60-day pediatric course. Historically Chagas therapy was accessible only through CDC investigational drug protocols; FDA approval of Lampit (2020) and benznidazole (2017) enables commercial access.
Chagas disease is caused by the Trypanosoma cruzi parasite, endemic in Latin America. Chronic infection causes cardiomyopathy (a major cause of heart failure in Latin America) and GI disease decades later. Pediatric treatment can cure infection before chronic organ damage. Congenital transmission is prevented via maternal treatment and infant screening. Increasingly recognized in Latin American immigrants and US-born congenitally infected patients.
Both are FDA-approved for pediatric Chagas disease. Benznidazole (also generic globally) is historically first-line — a 60-day course with a similar side effect profile. Lampit (nifurtimox) is an FDA-approved alternative — also a 60-day course. Choice is often by prescriber experience, side effect tolerability, and availability. Both have significant tolerability concerns in adults; pediatric use is generally better tolerated.
In the US, Lampit is FDA-approved only for pediatric use (birth to <18 years). Adult use is off-label or via investigational protocols. Benznidazole may also be used off-label in adults. Discuss with a tropical medicine or ID specialist. Globally, nifurtimox has been used in adults for decades.
Nausea, vomiting, abdominal pain, weight loss (very common — nutritional support important), headache, insomnia, dizziness. Serious: peripheral neuropathy, seizures, severe skin reactions, mental health effects. Avoid alcohol (disulfiram-like reaction). Pediatric tolerability is generally better than adult.
Chagas disease treatment prevents chronic organ damage — accessible therapy is critical. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.